498 related articles for article (PubMed ID: 23871904)
1. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
Wang XM; Xu J; Li YP; Li H; Jiang CS; Yang GD; Lu SM; Zhang SQ
Eur J Med Chem; 2013 Sep; 67():243-51. PubMed ID: 23871904
[TBL] [Abstract][Full Text] [Related]
2. Combination of 2-methoxy-3-phenylsulfonylaminobenzamide and 2-aminobenzothiazole to discover novel anticancer agents.
Li H; Wang XM; Wang J; Shao T; Li YP; Mei QB; Lu SM; Zhang SQ
Bioorg Med Chem; 2014 Jul; 22(14):3739-48. PubMed ID: 24878359
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
Kassab AE; Gedawy EM
Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo.
Wang XM; Xin MH; Xu J; Kang BR; Li Y; Lu SM; Zhang SQ
Eur J Med Chem; 2015; 96():382-95. PubMed ID: 25911625
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.
Kamel MM; Megally Abdo NY
Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
[TBL] [Abstract][Full Text] [Related]
10. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol.
Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM
Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722
[TBL] [Abstract][Full Text] [Related]
11. An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity.
Lauria A; Patella C; Abbate I; Martorana A; Almerico AM
Eur J Med Chem; 2013 Jul; 65():381-8. PubMed ID: 23747807
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of novel pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-one derivatives.
El-Nassan HB
Eur J Med Chem; 2011 Jun; 46(6):2031-6. PubMed ID: 21429629
[TBL] [Abstract][Full Text] [Related]
13. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel 1,2,4-triazolo [3,4-b][1,3,4] thiadiazines bearing furan and thiophene nucleus.
Zhang B; Li YH; Liu Y; Chen YR; Pan ES; You WW; Zhao PL
Eur J Med Chem; 2015 Oct; 103():335-42. PubMed ID: 26363869
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.
Xie W; Xie S; Zhou Y; Tang X; Liu J; Yang W; Qiu M
Eur J Med Chem; 2014 Jun; 81():22-7. PubMed ID: 24819956
[TBL] [Abstract][Full Text] [Related]
16. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents.
Husain A; Rashid M; Shaharyar M; Siddiqui AA; Mishra R
Eur J Med Chem; 2013 Apr; 62():785-98. PubMed ID: 23333063
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics.
Oguro Y; Cary DR; Miyamoto N; Tawada M; Iwata H; Miki H; Hori A; Imamura S
Bioorg Med Chem; 2013 Aug; 21(15):4714-29. PubMed ID: 23755884
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of γ-(triazolyl ethylidene)butenolides and polyfunctional pyrrolinones.
Devender N; Ramakrishna KK; Hamidullah ; Shukla SK; Konwar R; Tripathi RP
Eur J Med Chem; 2014 Jul; 82():106-19. PubMed ID: 24880230
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
